Search
SeaStar Medical Holding Corp
ICUAdd to Watchlist
3.130USD
-0.050-1.57%
Close 07-31 16:00（ET）Quotes delayed by 15 min
12.50MMarket Cap
LossP/E TTM
More Details of SeaStar Medical Holding Corp Company
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).
SeaStar Medical Holding Corp Info
Ticker SymbolICU
Company nameSeaStar Medical Holding Corp
IPO dateJan 26, 2021
CEOSchlorff (Eric)
Number of employees19
Security typeOrdinary Share
Fiscal year-endJan 26
Address3513 Brighton Blvd
CityDENVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80216
Phone18444278100
Websitehttps://seastarmedical.com
Ticker SymbolICU
IPO dateJan 26, 2021
CEOSchlorff (Eric)
Company Executives of SeaStar Medical Holding Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
15.81K
+65.07%
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
12.27K
+32.61%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
11.02K
+65.34%
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
6.69K
+59.82%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
4.27K
+93.74%
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
Mr. Michael Hollan Messinger, CPA
Mr. Michael Hollan Messinger, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Schlorff
Mr. Eric Schlorff
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
15.81K
+65.07%
Mr. John Neuman
Mr. John Neuman
Independent Director
Independent Director
12.27K
+32.61%
Dr. Kevin Chung, M.D.
Dr. Kevin Chung, M.D.
Chief Medical Officer
Chief Medical Officer
11.02K
+65.34%
Ms. Jennifer A. (Jen) Baird
Ms. Jennifer A. (Jen) Baird
Independent Chairman of the Board
Independent Chairman of the Board
6.69K
+59.82%
Ms. Bernadette N. Vincent
Ms. Bernadette N. Vincent
Independent Director
Independent Director
4.27K
+93.74%
Mr. Kenneth (Ken) Van Heel
Mr. Kenneth (Ken) Van Heel
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of SeaStar Medical Holding Corp?
The top five shareholders of SeaStar Medical Holding Corp are: Mr. Eric Schlorff
How many institutions hold shares of SeaStar Medical Holding Corp (ICU)?
As of 2026Q1, 51 institutions hold shares of SeaStar Medical Holding Corp, with a combined market value of approximately 94.83K, accounting for 2.37% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -86458.00.